CN102861288A - Traditional Chinese medicine composite for treating kidney stone - Google Patents
Traditional Chinese medicine composite for treating kidney stone Download PDFInfo
- Publication number
- CN102861288A CN102861288A CN2012103229390A CN201210322939A CN102861288A CN 102861288 A CN102861288 A CN 102861288A CN 2012103229390 A CN2012103229390 A CN 2012103229390A CN 201210322939 A CN201210322939 A CN 201210322939A CN 102861288 A CN102861288 A CN 102861288A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- fructus
- radix
- semen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composite for treating kidney stone. The traditional Chinese medicine composite comprises the following compositions in parts by weight: 100 parts of foxnut, 100 parts of lotus seed, 100 parts of cowherb seed, 45-55 parts of spora lygodii, 45-55 parts of christina loosestrife herb, 45-55 parts of pericarpium citri reticulatae, 45-55 parts of bighead atractylodes rhizome, 25-30 parts of liquorice, 28-32 parts of artemisia capillaries, 14-16 parts of gardenia, 14-16 parts of giant knot weed, 28-32 parts of endothelium corneum gigeriae galli, 18-22 parts of pangolin, 18-22 parts of immature bitter orange, 18-22 parts of radix curcumae, 14-16 parts of pericarpium citri reticulatae viride, 14-16 parts of walnut, 14-16 parts of rheum officinale, 4-6 parts of costus root, 14-16 parts of bunge cherry seed, 14-16 parts of Chinese lantern-plant, 14-16 parts of corn stigma, 4-6 parts of fructus amomi, 14-16 parts of scorched hawthorn fruit, 9-11 parts of golden cypress, 9-11 parts of bermuda grass and 4-6 parts of talcum powder. Each crude drug of the traditional Chinese medicine composite disclosed by the invention is coherent on with another so that the pesticide effect is played at the utmost; the traditional Chinese medicine composite has kidney-tonifying and calculus-removing effects and has the functions of inducing diuresis and increasing peristalsis of kidney and ureter as well as dissolving calculus; and the traditional Chinese medicine composite has good and rapid curative effect in treating renal calculus without any toxic and side effects and has the function of preventing renal calculus.
Description
Technical field
The present invention relates to the field of Chinese medicines, be specifically related to a kind of Chinese medicine composition for the treatment of renal calculus.
Background technology
Although renal calculus is a kind of benign disease, sometimes may stop up the discharge that urinary tract hinders urine, cause pain, hydronephrosis, serious may cause uremia even tumor.Long-term cholelithiasis is large especially to the harm of health, and the method for existing treatment cholelithiasis mostly is modus operandi and oral western medicine, and it is very big to patient's actual bodily harm to perform the operation, and the oral western medicine effect is bad, also has simultaneously side effect.
Summary of the invention
The invention discloses a kind of Chinese medicine composition for the treatment of renal calculus, this Chinese medicine composition has the kidney invigorating calculus removing effect, existing diuresis, can increase again kidney, ureteral wriggling function, the effect of lithodialysis is arranged again, treatment renal calculus good effect, instant effect, the effect of formation without any side effects, as to have simultaneously prevention renal calculus.
The technical solution used in the present invention is as follows:
A kind of Chinese medicine composition for the treatment of renal calculus, it is characterized in that, made by following crude drug, the weight portion of each crude drug is: Semen Euryales 100, Semen Nelumbinis 100, the king does not stay 100, Spora Lygodii 45-55, Herba Lysimachiae 45-55, Pericarpium Citri Reticulatae 45-55, Rhizoma Atractylodis Macrocephalae 45-55, Radix Glycyrrhizae 25-30, Herba Artemisiae Scopariae 28-32, Fructus Gardeniae 14-16, Rhizoma Polygoni Cuspidati 14-16, Endothelium Corneum Gigeriae Galli 28-32, Squama Manis 18-22, Fructus Aurantii Immaturus 18-22, Radix Curcumae 18-22, Pericarpium Citri Reticulatae Viride 14-16, Semen Juglandis 14-16, Radix Et Rhizoma Rhei 14-16, Radix Aucklandiae 4-6, Semen Pruni 14-16, Calyx Seu Fructus Physalis 14-16, Stigma Maydis 14-16, Fructus Amomi 4-6, Fructus Crataegi (parched to brown) 14-16, Cortex Phellodendri 9-11, Bermuda grass 9-11, Talcum 4-6.
The Chinese medicine composition of described treatment renal calculus, it is characterized in that, be comprised of following component, the weight portion of each component is: Semen Euryales 100, Semen Nelumbinis 100, king do not stay 100, Spora Lygodii 45-55, Herba Lysimachiae 50, Pericarpium Citri Reticulatae 50, the Rhizoma Atractylodis Macrocephalae 50, Radix Glycyrrhizae 30, Herba Artemisiae Scopariae 30, Fructus Gardeniae 15, Rhizoma Polygoni Cuspidati 15, Endothelium Corneum Gigeriae Galli 30, Squama Manis 20, Fructus Aurantii Immaturus 20, Radix Curcumae 20, Pericarpium Citri Reticulatae Viride 15, Semen Juglandis 15, Radix Et Rhizoma Rhei 15, the Radix Aucklandiae 5, Semen Pruni 15, Calyx Seu Fructus Physalis 15, Stigma Maydis 15, Fructus Amomi 5, Fructus Crataegi (parched to brown) 15, Cortex Phellodendri 10, Bermuda grass 10, Talcum 5.
Described Chinese medicine composition is characterized in that: can be prepared into according to the method for Chinese medicinal of routine any oral formulations commonly used.
Described Chinese medicine composition is characterized in that: described oral formulations can be pill, capsule, tablet, powder, granule or oral liquid
Usage and dosage: dosage of the present invention depends on concrete dosage form, the factors such as patient age, body weight, health status.General Requirements is:
For oral administration: 1) capsule: every day three times, each serving 2～5, every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2～4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 5 grams, warm water takes.4) granule: every day three times.Each 5 grams, warm water takes.
The various crude drug of Chinese medicine composition of the present invention are mutually coordinated can play together and are at utmost brought into play drug effect, has the kidney invigorating calculus removing effect, existing diuresis, can increase again kidney, ureteral wriggling function, the effect of lithodialysis is arranged again, treatment renal calculus good effect, instant effect, the effect of formation without any side effects, as to have simultaneously prevention renal calculus.But the self-coordination ability of Effective Raise patient body is significantly improved function and clinical subjective symptoms.
The specific embodiment
Further describe by the following examples the present invention, it should be understood that these embodiment only are used for the purpose of illustration, never are limited to the present invention.
Embodiment 1: the preparation of capsule
Take by weighing each raw material (g) by following weight portion: Semen Euryales 100, Semen Nelumbinis 100, king do not stay 100, Spora Lygodii 45, Herba Lysimachiae 55, Pericarpium Citri Reticulatae 45, the Rhizoma Atractylodis Macrocephalae 55, Radix Glycyrrhizae 30, Herba Artemisiae Scopariae 28, Fructus Gardeniae 16, Rhizoma Polygoni Cuspidati 16, Endothelium Corneum Gigeriae Galli 28, Squama Manis 18, Fructus Aurantii Immaturus 18, Radix Curcumae 22, Pericarpium Citri Reticulatae Viride 16, Semen Juglandis 16, Radix Et Rhizoma Rhei 16, the Radix Aucklandiae 4, Semen Pruni 14, Calyx Seu Fructus Physalis 16, Stigma Maydis 16, Fructus Amomi 6, Fructus Crataegi (parched to brown) 16, Cortex Phellodendri 9, Bermuda grass 9, Talcum 6.
Be ground into after each component mixing with above-mentioned weight and incapsulate and get final product after fine powder is crossed 1500 mesh sieves.
Embodiment 2: the preparation of granule
Take by weighing each raw material (g) by following weight portion: Semen Euryales 100, Semen Nelumbinis 100, king do not stay 100, Spora Lygodii 50, Herba Lysimachiae 50, Pericarpium Citri Reticulatae 48, the Rhizoma Atractylodis Macrocephalae 48, Radix Glycyrrhizae 28, Herba Artemisiae Scopariae 30, Fructus Gardeniae 15, Rhizoma Polygoni Cuspidati 15, Endothelium Corneum Gigeriae Galli 30, Squama Manis 20, Fructus Aurantii Immaturus 20, Radix Curcumae 19, Pericarpium Citri Reticulatae Viride 15, Semen Juglandis 15, Radix Et Rhizoma Rhei 15, the Radix Aucklandiae 5, Semen Pruni 15, Calyx Seu Fructus Physalis 15, Stigma Maydis 15, Fructus Amomi 5, Fructus Crataegi (parched to brown) 16, Cortex Phellodendri 11, Bermuda grass 11, Talcum 5.
Each raw material of above-mentioned weight fraction is mixed, after being ground into fine powder and crossing 1500 mesh sieves, add ethanol and make adhesive, add starch and do filler, be pressed into granule.
Embodiment 3: the preparation of tablet
Take by weighing each raw material (g) according to following weight portion: Semen Euryales 100, Semen Nelumbinis 100, king do not stay 100, Spora Lygodii 50, Herba Lysimachiae 50, Pericarpium Citri Reticulatae 50, the Rhizoma Atractylodis Macrocephalae 50, Radix Glycyrrhizae 30, Herba Artemisiae Scopariae 30, Fructus Gardeniae 15, Rhizoma Polygoni Cuspidati 15, Endothelium Corneum Gigeriae Galli 30, Squama Manis 20, Fructus Aurantii Immaturus 20, Radix Curcumae 20, Pericarpium Citri Reticulatae Viride 15, Semen Juglandis 15, Radix Et Rhizoma Rhei 15, the Radix Aucklandiae 5, Semen Pruni 15, Calyx Seu Fructus Physalis 15, Stigma Maydis 15, Fructus Amomi 5, Fructus Crataegi (parched to brown) 15, Cortex Phellodendri 10, Bermuda grass 10, Talcum 5.
Each raw material of above-mentioned weight portion is mixed, after being ground into fine powder and crossing 800～1200 order dusting covers, make tablet and get final product.
Embodiment 4: the preparation of pill
Take by weighing each raw material (g) according to following weight portion: Semen Euryales 100, Semen Nelumbinis 100, king do not stay 100, Spora Lygodii 55, Herba Lysimachiae 55, Pericarpium Citri Reticulatae 45, the Rhizoma Atractylodis Macrocephalae 45, Radix Glycyrrhizae 32, Herba Artemisiae Scopariae 32, Fructus Gardeniae 16, Rhizoma Polygoni Cuspidati 16, Endothelium Corneum Gigeriae Galli 29, Squama Manis 21, Fructus Aurantii Immaturus 20, Radix Curcumae 21, Pericarpium Citri Reticulatae Viride 15, Semen Juglandis 16, Radix Et Rhizoma Rhei 14, the Radix Aucklandiae 6, Semen Pruni 16, Calyx Seu Fructus Physalis 14, Stigma Maydis 14, Fructus Amomi 5, Fructus Crataegi (parched to brown) 14, Cortex Phellodendri 9, Bermuda grass 10, Talcum 5.
Each raw material of above-mentioned weight is mixed, be ground into cross 600～1000 sieves behind the fine powder after, make pill and get final product.
Embodiment 5: the preparation of oral liquid
Take by weighing each raw material (g) according to following weight portion: Semen Euryales 100, Semen Nelumbinis 100, king do not stay 100, Spora Lygodii 50, Herba Lysimachiae 54, Pericarpium Citri Reticulatae 46, the Rhizoma Atractylodis Macrocephalae 47, Radix Glycyrrhizae 30, Herba Artemisiae Scopariae 30, Fructus Gardeniae 15, Rhizoma Polygoni Cuspidati 15, Endothelium Corneum Gigeriae Galli 30, Squama Manis 22, Fructus Aurantii Immaturus 22, Radix Curcumae 22, Pericarpium Citri Reticulatae Viride 16, Semen Juglandis 16, Radix Et Rhizoma Rhei 14, the Radix Aucklandiae 5, Semen Pruni 16, Calyx Seu Fructus Physalis 15, Stigma Maydis 15, Fructus Amomi 4, Fructus Crataegi (parched to brown) 14, Cortex Phellodendri 10, Bermuda grass 10, Talcum 6.
Each raw material of above-mentioned weight is mixed, after decocting for three times, three filtrates are mixed, filter, be concentrated into the concentration of regulation, cooling, the stock solution embedding, irradiation sterilization, after the check, packed products is made oral liquid and be get final product.
Clinical observation: the present invention carries out clinical observation treatment to 500 routine patients, and the patient is men and women's age bracket, the oldest person 75 years old, and the age reckling only has 18 years old, is renal calculus, shows as lower abdominal pain, hematuria, painful urination, row and does not go out urine etc.Therapeutic Method: oral
1) capsule: every day three times, each serving 2～5, every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2～4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 5 grams, warm water takes.4) granule: every day three times.Each 5 grams, warm water takes.30 days is a course for the treatment of.
(1) efficacy assessment standard
Cure: the clinical symptoms sign disappears, and it is normal that functional activity recovers, and pain disappears, and it is normal to urinate, and indices recovers normal on inspection.
Produce effects: basic or most of disappearance of clinical symptoms sign, pain disappears substantially, and it is slightly not smooth to urinate, and majority parameters recovers normal on inspection.
Effectively: the clinical symptoms body is clearly better or takes a turn for the better, pain relief, and urinating slightly gets better turns, and indices slightly take a favorable turn on inspection.
Invalid: clinical symptoms sign thing improves, and Index for examination has no improvement.
(2) therapeutic effect:
The calculus granularity is that 0.1-0.5cm is considered as in early days, and 0.5-0.9cm is considered as mid-term, and 0.9cm is above to be late period.The calculus granularity is 0.1-0.4cm's, takes a course for the treatment of, can cure.For early, 400 patient treatment effects in mid-term are better, can cure general 1-3 course for the treatment of, for the renal calculus patient in late period through 4-6 the course for the treatment of 40 healings being arranged, 30 produce effects, 20 effective, 10 are invalid.Cure rate 88%, produce effects accounts for, and 6%, effectively account for 7%, invalidly account for 2%, total effective rate 98%.
Model case
1, Liu, man 45 years old, people from Hefei, No.1 Reople's Hospital, Hefei City was diagnosed as renal calculus in 2008, it is not obvious to have taken the some months western medicine result, and adopt the external stone crushing curative effect very little in February, 2009, after begin upon somebody's introduction to take Chinese medicinal granule of the present invention, every day three times, each serving 2～5, every content of dispersion 0.4 gram, warm water takes, cure 4 courses for the treatment of, so far not recurrence.
2, Zhu, woman, 18 years old, people from Chizhou City, on August 24th, 2008 examined, and abdominal pain, hematuria, painful urination, row do not go out urine, be diagnosed as renal calculus, take pill of the present invention, day takes 1 dose, fries in shallow oil moisture and takes for 2 to 3 times, urinated normal on the 6th day after taking medicine, after continue to take 2 courses for the treatment of of medicine of the present invention, cure the course for the treatment of, so far recurrence.
3, Chen, man, 65 years old, people from Xinhe River, on June 1st, 2010, head examined, and No.1 Reople's Hospital, Hefei City was diagnosed as renal calculus in 2009, it is not obvious to have taken the some months western medicine result, and adopt the external stone crushing curative effect very little in April, 2009, after begin upon somebody's introduction to take Chinese medicinal granule of the present invention, every day three times, each serving 2～5, every content of dispersion 0.4 gram, warm water takes, cure 4 courses for the treatment of, so far not recurrence.
Claims (4)
1. Chinese medicine composition for the treatment of renal calculus, it is characterized in that, made by following crude drug, the weight portion of each crude drug is: Semen Euryales 100, Semen Nelumbinis 100, the king does not stay 100, Spora Lygodii 45-55, Herba Lysimachiae 45-55, Pericarpium Citri Reticulatae 45-55, Rhizoma Atractylodis Macrocephalae 45-55, Radix Glycyrrhizae 25-30, Herba Artemisiae Scopariae 28-32, Fructus Gardeniae 14-16, Rhizoma Polygoni Cuspidati 14-16, Endothelium Corneum Gigeriae Galli 28-32, Squama Manis 18-22, Fructus Aurantii Immaturus 18-22, Radix Curcumae 18-22, Pericarpium Citri Reticulatae Viride 14-16, Semen Juglandis 14-16, Radix Et Rhizoma Rhei 14-16, Radix Aucklandiae 4-6, Semen Pruni 14-16, Calyx Seu Fructus Physalis 14-16, Stigma Maydis 14-16, Fructus Amomi 4-6, Fructus Crataegi (parched to brown) 14-16, Cortex Phellodendri 9-11, Bermuda grass 9-11, Talcum 4-6.
2. the Chinese medicine composition for the treatment of renal calculus according to claim 1, it is characterized in that, be comprised of following component, the weight portion of each component is: Semen Euryales 100, Semen Nelumbinis 100, king do not stay 100, Spora Lygodii 45-55, Herba Lysimachiae 50, Pericarpium Citri Reticulatae 50, the Rhizoma Atractylodis Macrocephalae 50, Radix Glycyrrhizae 30, Herba Artemisiae Scopariae 30, Fructus Gardeniae 15, Rhizoma Polygoni Cuspidati 15, Endothelium Corneum Gigeriae Galli 30, Squama Manis 20, Fructus Aurantii Immaturus 20, Radix Curcumae 20, Pericarpium Citri Reticulatae Viride 15, Semen Juglandis 15, Radix Et Rhizoma Rhei 15, the Radix Aucklandiae 5, Semen Pruni 15, Calyx Seu Fructus Physalis 15, Stigma Maydis 15, Fructus Amomi 5, Fructus Crataegi (parched to brown) 15, Cortex Phellodendri 10, Bermuda grass 10, Talcum 5.
3. according to claim 1 or 2 described Chinese medicine compositions, it is characterized in that: can be prepared into according to the method for Chinese medicinal of routine any oral formulations commonly used.
4. according to Chinese medicine composition claimed in claim 3, it is characterized in that: described oral formulations can be pill, capsule, tablet, powder, granule or oral liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210322939 CN102861288B (en) | 2012-09-04 | 2012-09-04 | Traditional Chinese medicine composite for treating kidney stone |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210322939 CN102861288B (en) | 2012-09-04 | 2012-09-04 | Traditional Chinese medicine composite for treating kidney stone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102861288A true CN102861288A (en) | 2013-01-09 |
| CN102861288B CN102861288B (en) | 2013-11-06 |
Family
ID=47440603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210322939 Expired - Fee Related CN102861288B (en) | 2012-09-04 | 2012-09-04 | Traditional Chinese medicine composite for treating kidney stone |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102861288B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103316284A (en) * | 2013-04-22 | 2013-09-25 | 山东省立医院 | Cholelithiasis treatment drug |
| CN107715027A (en) * | 2017-11-22 | 2018-02-23 | 宋志芳 | Treat the Chinese medicine composition of kidney stone |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1048324A (en) * | 1989-06-30 | 1991-01-09 | 杨翠玉 | The manufacture method of stone-dissolving medicine " Rongshibao " |
| CN1334119A (en) * | 2001-07-26 | 2002-02-06 | 王继平 | Litholysizing bear gall powder |
| CN1389234A (en) * | 2001-06-12 | 2003-01-08 | 苏东升 | Lithiasis treating medicine |
| CN101953982A (en) * | 2010-10-04 | 2011-01-26 | 杨鲲 | Traditional Chinese medicine plaster for treating chronic pyelonephritis |
| CN102302735A (en) * | 2011-08-26 | 2012-01-04 | 陈遇献 | Calculus removing medicine |
| CN102335300A (en) * | 2010-07-23 | 2012-02-01 | 李永春 | Stone decomposing and discharging medicament |
-
2012
- 2012-09-04 CN CN 201210322939 patent/CN102861288B/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1048324A (en) * | 1989-06-30 | 1991-01-09 | 杨翠玉 | The manufacture method of stone-dissolving medicine " Rongshibao " |
| CN1389234A (en) * | 2001-06-12 | 2003-01-08 | 苏东升 | Lithiasis treating medicine |
| CN1334119A (en) * | 2001-07-26 | 2002-02-06 | 王继平 | Litholysizing bear gall powder |
| CN102335300A (en) * | 2010-07-23 | 2012-02-01 | 李永春 | Stone decomposing and discharging medicament |
| CN101953982A (en) * | 2010-10-04 | 2011-01-26 | 杨鲲 | Traditional Chinese medicine plaster for treating chronic pyelonephritis |
| CN102302735A (en) * | 2011-08-26 | 2012-01-04 | 陈遇献 | Calculus removing medicine |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103316284A (en) * | 2013-04-22 | 2013-09-25 | 山东省立医院 | Cholelithiasis treatment drug |
| CN103316284B (en) * | 2013-04-22 | 2014-09-10 | 山东省立医院 | Cholelithiasis treatment drug |
| CN107715027A (en) * | 2017-11-22 | 2018-02-23 | 宋志芳 | Treat the Chinese medicine composition of kidney stone |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102861288B (en) | 2013-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101869691B (en) | Chinese medicinal composition for treating dysmenorrhea and preparation method thereof | |
| CN101816742A (en) | Chinese medicinal composition for treating hemorrhoids and preparation method thereof | |
| CN101785845B (en) | Traditional Chinese medicine combination and preparation method for intestinal flatulence treatment | |
| CN102526616B (en) | Chinese medicinal herb pills for treating cholecystitis and gallstone | |
| CN101757566A (en) | Traditional Chinese medicine composition for treating colon cancer and preparation method thereof | |
| CN101785847A (en) | Traditional Chinese medicine combination for intestinal caner treatment and preparation method thereof | |
| CN103341064B (en) | Chinese medicine composition for treating urine retention | |
| CN101874878B (en) | Chinese medicinal composition for treating hematemesis and preparation method thereof | |
| CN101961480A (en) | Traditional Chinese medicinal composition for treating hematochezia and preparation method thereof | |
| CN101810835A (en) | Chinese medicinal composition for treating purpura and preparation method thereof | |
| CN101810823B (en) | Chinese medicinal composition for treating renal cyst diseases and use of preparing medicine | |
| CN101589754B (en) | Traditional Chinese medicine health tea capable of soothing nerves and promoting blood circulation | |
| CN102895444B (en) | Traditional Chinese medicine composition for treating lithangiuria | |
| CN102861288B (en) | Traditional Chinese medicine composite for treating kidney stone | |
| CN101843888B (en) | Novel Chinese medicinal composition for treating menorrhagia and a preparation method thereof | |
| CN100548363C (en) | Medicine of treatment benign prostate hyperplasia and preparation method thereof | |
| CN104587252A (en) | Traditional Chinese medicine composition for treating kidney stones | |
| CN104524372A (en) | Traditional Chinese medicine preparation for treating cervical cancer | |
| CN101357187A (en) | Medicine for treating the prostatitis | |
| CN103599407B (en) | A kind ofly be used for the treatment of prostatitis and with the Chinese medicine composition of insomnia and dreamful sleep | |
| CN106075180A (en) | A kind of Chinese medicine treating intravertebral anesthesia postoperative urine retention and preparation method thereof | |
| CN105560994A (en) | Traditional Chinese medicine composition for treating prolapse of uterus | |
| JP2007153777A (en) | Composition having urinary tract symptom-ameliorating effect | |
| CN1264566C (en) | Medicine for treating prostatosis | |
| CN105148050A (en) | Traditional Chinese medicinal composition for treating kidney stone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131106 Termination date: 20170904 |